SELPLG and glioblastoma: Using these criteria, we found 17 glycopeptides dissimilar between different group comparisons, including GBM versus control, GBM (no CLA) versus control, PRO versus control, MES versus control, CLA versus control, MES versus PRO, CLA versus PRO, and CLA versus MES.